BlackRock’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-776,613
| Closed | -$94M | – | 5545 |
|
|
2023
Q1 | $94M | Sell |
776,613
-7,095
| -0.9% | -$859K | ﹤0.01% | 2038 |
|
|
2022
Q4 | $90M | Sell |
783,708
-226,111
| -22% | -$26M | ﹤0.01% | 2050 |
|
|
2022
Q3 | $102M | Buy |
1,009,819
+10,943
| +1% | +$1.11M | ﹤0.01% | 1936 |
|
|
2022
Q2 | $101M | Sell |
998,876
-4,848
| -0.5% | -$492K | ﹤0.01% | 1971 |
|
|
2022
Q1 | $117M | Sell |
1,003,724
-56,166
| -5% | -$6.54M | ﹤0.01% | 2015 |
|
|
2021
Q4 | $122M | Buy |
+1,059,890
| New | +$122M | ﹤0.01% | 2055 |
|
|
2020
Q4 | – | Sell |
-944,639
| Closed | -$106M | – | 5086 |
|
|
2020
Q3 | $106M | Buy |
944,639
+18,154
| +2% | +$2.03M | ﹤0.01% | 1823 |
|
|
2020
Q2 | $97M | Buy |
+926,485
| New | +$97M | ﹤0.01% | 1843 |
|